Konica Minolta Inc. said Thursday that it will partner with Innovation Network Corp. of Japan to buy the U.S. genetic testing firm Ambry Genetics Corp. for up to $1 billion.
Under the deal set to be closed in October, Konica Minolta will take a 60 percent stake in Ambry Genetics, with the INCJ, a state-backed investment fund, taking the rest.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.